Vor Biopharma Inc. (VOR) earnings
VOR earnings moved a median of -1.24% by the close. Quarterly and annual VOR reports and results, each read against the price at its own news timestamp. Back to the VOR overview →
18 measured VOR earnings events.
Where these VOR earnings landedvs 18 measured VOR earnings reactions
| Middle 50% of VOR earnings reactions | -2.30% to +4.21% |
|---|---|
| Median reaction (to close) | -1.24% |
| Measured reactions | 18 |
Point-in-time · zero look-ahead
Half of the 18 VOR earnings events with a measured close landed between -2.30% and +4.21%; 44% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q Vor Biopharma Inc. For: Jun 30 | SEC filing · Form 10-Q | -0.35% | +2.39% | |
| Vor Bio Reports Second Quarter 2026 Financial Results and Provides Corporate Update | Press release | -1.36% | +2.06% | |
| Form 10-Q Vor Biopharma Inc. For: Mar 31 | SEC filing · Form 10-Q | +0.86% | -1.97% | |
| Vor Bio Reports First Quarter 2026 Financial Results and Provides Corporate Update | Press release | +0.86% | -1.97% | |
| Form 10-K Vor Biopharma Inc. For: Dec 31 | SEC filing · Form 10-K | +1.06% | +0.27% | |
| Form 10-Q Vor Biopharma Inc. For: Jun 30 | SEC filing · Form 10-Q | -0.49% | -2.42% | |
| Form 10-Q Vor Biopharma Inc. For: Mar 31 | SEC filing · Form 10-Q | +3.73% | +5.62% | |
| Form 10-K Vor Biopharma Inc. For: Dec 31 | SEC filing · Form 10-K | +4.22% | +4.82% | |
| Form 10-Q Vor Biopharma Inc. For: Sep 30 | SEC filing · Form 10-Q | +0.65% | +14.99% | |
| Vor Bio Reports Third Quarter 2024 Financial Results and Provides Company Update | Press release | +0.65% | +14.99% | |
| Form 10-Q Vor Biopharma Inc. For: Jun 30 | SEC filing · Form 10-Q | +2.37% | -1.24% | |
| Form 10-Q/A Vor Biopharma Inc. For: Mar 31 | SEC filing · Form 10-Q | +2.37% | -1.24% | |
| Vor Bio Reports Second Quarter 2024 Financial Results and Provides Company Update | Press release | +2.37% | -1.24% | |
| Form 10-Q Vor Biopharma Inc. For: Mar 31 | SEC filing · Form 10-Q | +1.42% | -2.84% | |
| Vor Bio Reports First Quarter 2024 Financial Results and Provides Company Update | Press release | +1.42% | -2.84% | |
| Form 10-K Vor Biopharma Inc. For: Dec 31 | SEC filing · Form 10-K | +3.32% | +8.89% | |
| Form 10-Q Vor Biopharma Inc. For: Sep 30 | SEC filing · Form 10-Q | +0.49% | -8.82% | |
| Vor Bio Reports Third Quarter 2023 Financial Results and Provides Company Update | Press release | +0.49% | -8.82% |
Keep exploring
More VOR: analyst actions → · SEC filings → · VOR overview →